A detailed history of Americana Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Americana Partners, LLC holds 28,018 shares of AZN stock, worth $2.23 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
28,018
Previous 27,130 3.27%
Holding current value
$2.23 Million
Previous $1.84 Million 18.88%
% of portfolio
0.19%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$66.81 - $80.83 $59,327 - $71,777
888 Added 3.27%
28,018 $2.19 Million
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $116,811 - $133,156
1,914 Added 7.59%
27,130 $1.84 Million
Q4 2023

Jan 25, 2024

SELL
$61.89 - $69.28 $179,914 - $201,396
-2,907 Reduced 10.34%
25,216 $1.7 Million
Q3 2023

Nov 07, 2023

BUY
$64.85 - $71.7 $220,036 - $243,278
3,393 Added 13.72%
28,123 $1.9 Million
Q2 2023

Jul 31, 2023

SELL
$69.91 - $75.81 $1.17 Million - $1.27 Million
-16,771 Reduced 40.41%
24,730 $1.77 Million
Q1 2023

May 08, 2023

BUY
$63.15 - $71.6 $9,219 - $10,453
146 Added 0.35%
41,501 $2.88 Million
Q4 2022

Jan 30, 2023

SELL
$54.21 - $70.44 $1.1 Million - $1.43 Million
-20,239 Reduced 32.86%
41,355 $2.8 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $1.25 Million - $3.19 Million
23,493 Added 61.66%
61,594 $3.38 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $470,642 - $564,993
7,942 Added 26.33%
38,101 $2.48 Million
Q1 2022

May 06, 2022

BUY
$55.72 - $67.12 $521,817 - $628,578
9,365 Added 45.04%
30,159 $720,000
Q4 2021

Jan 28, 2022

BUY
$54.02 - $63.83 $1.12 Million - $1.33 Million
20,794 New
20,794 $1.21 Million
Q1 2020

May 12, 2020

SELL
$37.79 - $51.33 $28,153 - $38,240
-745 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$42.46 - $50.46 $31,632 - $37,592
745 New
745 $37,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Americana Partners, LLC Portfolio

Follow Americana Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Americana Partners, LLC with notifications on news.